A short, patient-led diagnostic to identify trust, adoption, and adherence risks that clinical data alone cannot show.
Strong clinical evidence does not guarantee real-world uptake.
Market Access teams often lack early visibility on the "human" variables that weaken payer confidence or downstream outcomes. By the time these are discovered, strategy is often already fixed.
10–15 in-depth conversations led by lived-experience experts. We conduct these outside crisis moments (in stable-state conditions) to understand the real decision-making environment.
We map emotional, cognitive, and trust barriers across the patient journey, identifying specific moments where information, framing, or support fails to connect.
Synthesis of risks into actionable recommendations aligned with Market Access priorities. No noise. No storytelling for storytelling’s sake.
Trusted access to lived-experience communities, bypassing traditional "researcher" bias.
We focus on decision-making drivers, not storytelling for storytelling's sake.
Designed to plug into existing medical and access work, not duplicate it.
“This is a low-risk diagnostic to test whether patient trust or behavior could undermine uptake, even when clinical evidence is strong.”